Skip to main content
SpringerLink
Log in

Risk of liver toxicity, drug interactions with sitaxentan

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Encysive Pharmaceuticals.Safety information regarding THELIN TM (sitaxsentan sodium) and the occurrence of liver toxicity, risks to the fetus, and important drug-drug interactions. Internet Document: [5 pages], 9 Jul 2007. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risk of liver toxicity, drug interactions with sitaxentan. React. Wkly. 1167, 2 (2007). https://doi.org/10.2165/00128415-200711670-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711670-00003

Keywords

Search

Navigation